Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial (Q34124712)

31 July 2017

Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial (English)

1 reference

31 July 2017

0 references

1 reference

IONA Study Group

1

1 reference

PubMed ID

11965271

31 July 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

31 July 2017

1 reference

31 July 2017

359

1 reference

31 July 2017

9314

1 reference

31 July 2017

1269-1275

1 reference

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Nicorandil as a hybrid between nitrates and potassium channel activators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Mechanisms of cardiac pain during coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Preconditioning the human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Unstable Angina : An Etiologic Approach to Management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Role of ATP dependent potassium channels in myocardial ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Angina reassessed: pain or protector?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908265-X

7 January 2021

10.1016/S0140-6736(02)08265-X

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11965271